Zdrowie i gospodarka · 13.01.1998
Administrative Proceeding; Re: Pharmanex, Inc.
The Food and Drug Administration (FDA) is announcing that comments related to the regulatory status of Cholestin TM may be submitted until January 30, 1998. This action is being taken as a part of the agency's deliberation on the regulatory status of Cholestin TM . All comments postmarked on or before January 30, 1998, will be accepted as part of the official record for this matter.